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Respiratory cryptosporidiosis has been documented in children with diarrhea. We sought to
describe the dynamics of respiratory involvement in children hospitalized with gastrointesti-
nal (GI) diarrheal disease.
Methods
We conducted a prospective, observational longitudinal study of Malawian children 2–24
months hospitalized with diarrhea. Nasopharyngeal (NP) swabs, induced sputum and stool
specimens were collected. Participants that were positive by Cryptosporidium PCR in any of
the three compartments were followed up with fortnightly visits up to 8 weeks post-
enrollment.
Results
Of the 162 children recruited, participants had mild-moderate malnutrition (mean HAZ -1.6
(SD 2.1)), 37 (21%) were PCR-positive for Cryptosporidium at enrollment (37 stool, 11 spu-
tum, and 4 NP) and 27 completed the majority of follow-up visits (73%). Cryptosporidium
was detected in all compartments over the 4 post-enrollment visits, most commonly in stool
(100% at enrollment with mean cycle thresholds (Ct) of 28.8±4.3 to 44% at 8 weeks with Ct
29.9±4.1), followed by sputum (31% at enrollment with mean Ct 31.1±4.4 to 20% at 8 weeks
with Ct 35.7±2.6), then NP (11% with mean Ct 33.5±1.0 to 8% with Ct 36.6±0.7). Partici-
pants with Cryptosporidium detection in both the respiratory and GI tract over the study
period reported respiratory and GI symptoms in 81% and 62% of study visits, respectively,
compared to 68% and 27%, respectively, for those with only GI detection, and had longer GI
shedding (17.5±6.6 v. 15.9±2.9 days).
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Conclusion
Cryptosporidium was detected in both respiratory and GI tracts throughout the 8 weeks
post-enrollment. The development of therapeutics for Cryptosporidium in children should
target the respiratory as well as GI tract.
Author summary
We conducted a prospective, observational longitudinal study of Malawian children 2–24
months hospitalized with diarrhea. NP swabs, induced sputum and stool specimens were
collected. Participants that were positive by Cryptosporidium PCR in any of the three com-
partments were followed up with fortnightly visits up to 8 weeks post-enrollment. Crypto-
sporidium was detected by PCR in 21%, 7% and 3% in stool, sputum and nasopharynx of
children hospitalized with diarrhea. Of those positive at enrollment, detection was noted
in 44%, 20%, and 8%, respectively, by 8 weeks post-enrollment.
Introduction
Cryptosporidiosis is a cause of diarrhea [1–3], excess mortality [4,5], stunting [1,6], and is
associated with malnutrition [6,7]. The Global Enteric Multicenter Study (GEMS) identified
Cryptosporidium as second most common cause of diarrhea among infants (0–11 months) in
all four African countries studied (The Gambia, Mali, Mozambique, Kenya) regardless of HIV
prevalence, and among the top five causes for older children (12–23 months) [4]. Respiratory
cryptosporidiosis has been documented in up to a third of children presenting with diarrhea
[8]; furthermore, respiratory detection without intestinal involvement has been reported
[9,10], raising the possibility of primary respiratory infection with Cryptosporidium, either by
inhalation or by contact with fomites [11].
Studies have identified Cryptosporidium in sputum but have not looked at whether respira-
tory involvement is a transient phenomenon or a reservoir for gastrointestinal (GI) disease.
This has implications for therapeutic development. Our primary objective was to evaluate
whether respiratory involvement of Cryptosporidium is a transient phenomenon in diarrheal
disease, and to assess for respiratory and GI cryptosporidiosis concurrently and longitudinally
in children hospitalized with diarrheal disease.
Methods
Ethics statement
The study was approved by the University of Malawi College of Medicine Research Ethics
Committee (P.07/18/2438) and the Liverpool School of Tropical Medicine Research Ethics
Committee (18–066). Written consent was obtained from parents or guardians prior to
enrollment.
Study design, setting, and participants
We conducted a prospective, observational-longitudinal study of Malawian children hospital-
ized with diarrhea [12]. Children aged 2–24 months and presenting with primary GI symp-
toms to Queen Elizabeth Central Hospital (QECH) in Blantyre, Malawi, were screened.
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Eligible patients were those with at least three or more loose stools within the past 24 hours.
Those with dysentery, or visible blood in loose stools, were excluded.
Clinical procedures
Once written consent was obtained, a detailed history and physical exam was conducted and
all then enrolled subjects had a NP swab, induced sputum, and stool sample collected. For
induced sputum collection, subjects were given a nebulized 3% sodium chloride mist to inhale
for 5–15 minutes. For infants, suctioning of the oropharynx was done after nebulization to col-
lect the specimen. To ensure safety of the subject, induced sputum was only collected if there
were no contraindications (based on PERCH criteria for induced sputum collection) [13]:
severe hypoxia <92% on supplemental oxygen; inability to protect airways; severe broncho-
spasm at admission (defined as continued hypoxia <92% after appropriate bronchodilator
therapy, with other markers of respiratory distress); seizure within the past 24 hours; or
deemed inappropriate by the clinician for another reason (e.g. midface trauma, inhalational
injury, pulmonary effusion, congestive heart failure, congenital heart disease, etc). If the above
symptoms/conditions resolved within 48 hours, induced sputum collection was reconsidered
at that point.
HIV rapid testing was conducted on infants and, if positive, infants were referred to the
pediatric HIV clinic for further care. Any relevant lab investigations (including full blood
count, urea and electrolytes, liver function tests, malaria parasite screen, blood and/or CSF cul-
ture, TB GeneXpert and AFB testing) performed as part of routine care were recorded.
All participating children had enrollment NP, sputum and stool specimens evaluated for
Cryptosporidium by PCR. Sputum quality was evaluated by microscopy (good quality:�10
squamous epithelial cells/high powered field). Only subjects where Cryptosporidium was
detected by PCR on any one of NP/sputum/stool were followed up in the post-enrollment
phase up to 8 weeks post-enrollment, with a follow-up visit every two weeks for evaluation of
symptoms, physical assessment, as well as NP/sputum/stool sampling.
Laboratory procedures
DNA was extracted in stool using QIAamp Fast Stool Mini Kit (Qiagen, Hilden, Germany)
and for respiratory tract using the QIAamp DNA mini kit (Qiagen) for Cryptosporidium [14],
and UCP Mini kit (Qiagen) for respiratory co-pathogens. Cryptosporidium detection of speci-
mens at enrollment were measured using quantitative polymerase chain reaction (qPCR), with
appropriate positive and negative controls. In subsequent follow-up samples in stool, Crypto-
sporidium was detected using qPCR in a TaqMan Array Card (Thermo Fisher, Waltham, MA)
using a custom design developed at the Houpt Laboratory (Charlottesville, VA) [15] and tested
for 28 enteropathogens: rotavirus, norovirus GII, adenovirus, astrovirus, sapovirus, enterotoxi-
genic Escherichia coli (ETEC), enteropathogenic E. coli (EPEC), enteroaggregative E. coli
(EAEC), Shiga-toxigenic E. coli (STEC), Shigella/enteroinvasive E. coli (EIEC), Salmonella,
Campylobacter jejuni/C. coli, Vibrio cholerae, Clostridium difficile, Cryptosporidium, Giardia
lamblia, Entamoeba histolytica, Ascaris lumbricoides, and Trichuris trichiura. In sputum, for
multiplex PCR we used the respiratory pathogens 33 kit (Fast Track Diagnostics, Luxembourg,
Luxembourg) which detected: S. pneumoniae, S. aureus, M. catarrhalis, B. pertussis, H. influen-
zae and H. influenzae type b, C. pneumoniae, M. pneumoniae, K. pneumoniae, L. pneumophila,
and Salmonella species, influenza A/B/C, RSV A/B, parainfluenza virus types 1–4, coronavi-
ruses NL63, 229E, OC43, and HKU1, human metapneumovirus A/B, rhinovirus, adenovirus,
enterovirus, parechovirus, bocavirus, cytomegalovirus, and P. jirovecii.
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Statistical analysis
Frequencies and proportions of observed levels were reported for binary and categorical vari-
ables, with exact binomial 95% confidence intervals given where appropriate. Comparisons
were performed using the Fisher’s exact test for binary and categorical variables, t-test (two
groups) or ANOVA (three or more groups) for approximately normally distributed variables
and Wilcoxon rank sum (2 groups) or Kruskal-Wallis (3 or more groups) tests for variables
with severely nonparametric distributions. Statistical analysis was performed using Stata soft-
ware, version 16, and statistical significance was set at 0.05.
Results
From 1 March 2019 to 3 April 2020, 162 children were recruited into the study. Two children
did not submit specimens. Of the remaining 160 children, 37 (21%) were positive in any one
of the three samples collected (37 stool (21%), 11 sputum (7%), and 4 NP (2%)) and were
entered into follow-up. The study was discontinued early due to COVID-19, by which time 27
children had completed at least three of the four follow-up visits (73%).
Among the 162 children who were hospitalized with diarrhea, the mean age was 11.6±5.0
months, and 59% were male (Table 1). Mean height-for-age (HAZ), weight-for-age (WAZ),
and weight-for-height (WHZ) z scores were -1.6±2.1, -1.0±1.3, and 0.1±1.6, respectively. Fif-
teen percent of mothers were HIV-infected, and five of those children tested positive by HIV
rapid test (3% of total). The participants had a mean of 4.5±1.4 persons in a household, and
the majority of children had access to a pit toilet/latrine (95%), piped drinking water (78%),
and harbored a residential animal in the compound (66%). Among the 37 children who were
Cryptosporidium PCR-positive, the mean age was 11.8±4.9 months, 65% were male and two
(6%) were positive by HIV rapid test. No significant differences in characteristics between chil-
dren who were Cryptosporidium-positive versus -negative were noted (S1 Table).
Induced sputum quality at enrollment was good in 82%, poor in 9% and unreadable in 9%,
with similar proportions of good quality sputum among Cryptosporidium-positive and -nega-
tive participants (81% and 82%, respectively). Over the 8-week period, Cryptosporidium was
detected in both respiratory and GI tracts (Table 2): most commonly in stool (100% at enroll-
ment to 44% at 8 weeks), followed by sputum (31% at enrollment to 20% at 8 weeks), then NP
(11% to 8%). Lowest Ct counts were generally noted in the stool (mean Ct 28.8±4.3 at enroll-
ment to 29.9±4.1 at 8 weeks), followed by sputum (mean Ct 31.1± 4.4 at enrollment to 35.7
±2.6 at 8 weeks), and NP ((mean Ct 33.5±1.0 to 36.6±0.7); Fig 1). When stratified by age,
infants 2–11 months had lower stool Ct counts compared to those 12–24 months (mean Ct
27.5±4.4 v. 30.2±3.5), but this was not statistically significant (S2 Table). We detected Crypto-
sporidium in respiratory but not GI tract in 6 study visits. All NP-positive subjects were also
sputum-positive, with the exception of one case at enrollment, a 15 month-old male with no
respiratory symptoms in whom Cryptosporidium was detected in the NP (Ct 35.6) and stool
(Ct 35.7), but not sputum. Detection in the respiratory tract did not always correlate with
symptoms (Fig 2A–2H). For individual participants in whom Cryptosporidium was detected at
enrollment, detection was noted most consistently in the GI tract throughout the 8 weeks.
Respiratory co-pathogens were detected in 87/104 (84%) visits over the follow-up period.
Respiratory symptoms were noted in 72% of Cryptosporidium-positive participants at
enrollment, the most common symptom being cough (69%), but also included runny nose
(46%), crackles (17%) and wheeze (11%). For those entered into the 8-week follow-up period,
participants with Cryptosporidium positivity in the respiratory tract had respiratory symptoms
in 23/43 (53%) of visits.
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Table 1. Characteristics of children hospitalized with diarrhea at enrollment.
Characteristic Children with diarrhea (n = 162)a Cryptosporidium -positive (n = 37) Cryptosporidium -negative (n = 123) P value
Demographics
Age, months, mean (SD) 11.6 (5.0) 11.8 (4.9) 11.5 (5.1) 0.897
2–11 months 90 (56%) 24 (60%) 65 (53%) 0.565
12–24 months 72 (44%) 13 (40%) 58 (47%)
Male sex 95 (59%) 24 (65%) 70 (57%) 0.649
Mother is employed (%) 72 (44%) 20 (54%) 52 (42%) 0.208
Number of household members (SD) 4.5 (1.4) 4.2(1.4) 4.5(1.4) 0.204
Children<5 years (SD) 1.3 (0.5) 1.2 (0.6) 1.3 (0.5) 0.533
Residential animals in the compound (%) 107 (66%) 22 (59%) 84 (68%) 0.359
Facility for disposing feces in households
(%)
Pit toilet/latrine 154 (95%) 36 (97%) 116 (94%) 0.686
Pour/flush toilet 8 (5%) 1 (3%) 7 (6%)
Child health indicators
Mother HIV status (%)
Positive 25 (15%) 8 (22%) 17 (14%) 0.391
Unknown 55 (34%) 10 (29%) 42 (34%)
Child HIV rapid test (%)
Positive 5 (3%) 2 (6%) 3 (2%) 0.158
Unknown/not done 120 (74%) 24 (63%) 94 (76%)
Z score (SD)
HAZ -1.6 (2.1) -1.4 (2.1) -1.6 (2.1) 0.552
WAZ -1.0 (1.3) -1.0 (1.3) -0.9 (1.3) 0.831
WHZ 0.1 (1.6) -0.1 (1.6) 0.2 (2.3) 0.396
MUAC, cm (SD) 13.7 (1.4) 13.7 (1.3) 13.8 (1.4) 0.692
Bipedal edema (%) 5 (3%) 1 (3%) 4 (3%) 1.000
Enrollment vitals and symptoms
Temperature, ˚C (SD) 36.7 (0.7) 36.7 (0.6) 36.8 (0.7) 0.422
Respiratory rate, breaths/min (SD) 36 (6.1) 36.4 (8.4) 35.9 (5.3) 0.902
Oxygen saturations, % (SD) 98.6 (1.4) 98.6 (1.4) 98.7 (1.4) 0.719
GI symptoms (%)
Vomiting 70 (43%) 18 (48%) 50 (41%) 0.847
Abdominal pain/ tenderness 65 (40%) 13 (35%) 50 (41%) 0.330
Poor feeding 66 (40%) 14 (38%) 50 (41%) 0.945
Dehydration 90 (56%) 21 (57%) 68 (55%) 0.845
Respiratory symptoms (%)
Cough 98 (61%) 25 (68%) 71 (58%) 0.283
Runny nose 58 (36%) 17 (46%) 39 (32%) 0.150
Difficulty in breathing 3 (2%) 1 (3%) 2 (2%) 0.531
Wheezing 14 (9%) 4 (11%) 9 (7%) 0.487
Chest indrawings/retractions 2 (1%) 0 2 (2%) 1.000
Crackles 17 (11%) 6 (17%) 10 (8%) 0.125
Cryptosporidium-PCR positive
Stool (%) 37 (21%) 37 (100%) 0 <0.001
Induced sputum (%) 11 (7%) 11 (31%) 0 <0.001
NP (%) 4 (2%) 4 (11%) 0 <0.001
Sputum quality (%)
(Continued)
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Among participants with Cryptosporidium detection in both the respiratory and GI tract at
enrollment compared to those with Cryptosporidium detection in the GI tract only (Table 3), a
larger proportion reported respiratory symptoms (90% v. 65%), and GI shedding of Cryptospo-
ridium was longer (14.3±2.1 v. 14.1±0.7 days), but these were not statistically significant.
Among participants whom Cryptosporidium was detected in both the respiratory and GI tract
at any point over the 8-week study period compared to GI tract only, a larger proportion
reported respiratory (81% v. 68%) and GI symptoms (62% v. 27%) per study visit, and GI shed-
ding of Cryptosporidium was longer (17.5±6.6 v. 15.9±2.9 days), but again these were not statis-
tically significant.
Discussion
This is the first longitudinal study to evaluate the respiratory cryptosporidiosis in pediatric
diarrheal disease. In children hospitalized with diarrheal disease, Cryptosporidium was
detected most frequently in stool, followed by sputum and NP. The most common respiratory
symptom was cough. Longitudinally, we detected Cryptosporidium in both respiratory and GI
tracts through 8 weeks post-enrollment, usually at lowest Ct counts in stool, followed by spu-
tum and then NP. Longer GI shedding of Cryptosporidium was noted among those where we
detected Cryptosporidium in both the respiratory and GI tracts, compared to GI detection
only, although findings did not reach statistical significance.
Our Cryptosporidium detection rate is far higher than has been reported in diarrhea studies
in sub-Saharan Africa, with rates of positivity ranging from 9% in Kenya to 14.7% in Mozam-
bique [4,8]. Subclinical Cryptosporidium infection was noted to be high (6%) in Tanzania [16].
A previous study done at QECH found Cryptosporidium to be the third most common cause
of diarrhea with a prevalence in stool of 28% among cases [17]. In our study, the positivity rate
was 21%, and this would be 12% if we used the GEMS diarrheagenic cutoffs [18]. This thus
supports the high prevalence of Cryptosporidium infection among young children hospitalized
with diarrheal illness in sub-Saharan Africa.
Few studies, however, have evaluated the prevalence of respiratory cryptosporidiosis in
pediatric diarrheal disease. A study in Uganda detected Cryptosporidium in 35.4% of induced
sputum samples from children presenting with diarrhea who were Cryptosporidium-positive
in the stool [8]. In our study, cough was noted in almost two-thirds of children presenting
with diarrhea, and the frequency of respiratory signs and symptoms tended to be higher, but
were not significantly different between those with Cryptosporidium-positive and -negative
stool samples. In addition to sampling the lower respiratory tract with induced sputum, we
Table 1. (Continued)
Characteristic Children with diarrhea (n = 162)a Cryptosporidium -positive (n = 37) Cryptosporidium -negative (n = 123) P value
Good (�10 sq epis/hpf) 131/160 (82%) 30 (81%) 101 (82%) 0.013
Poor (>10 sq epis/hpf) 15/160 (9%) 1 (3%) 14 (12%)
Unreadableb 14/160 (9%) 6 (17%) 8 (7%)
Outcomes
Mortality, inpatient (%) NA 0 NA
Mortality, post-discharge (%) NA 1 (3%) NA
GI, gastrointestinal; HAZ, Height-for-age z score; HPF, high powered field; MUAC, mid-upper arm circumference; NA, not applicable; SD, standard deviation; WAZ,
Weight-for-age z score; WHZ, Weight-for-height z score
a2/162 withdrew at enrolment, 1 submitted a respiratory but not a stool sample.
bUnable to assess sputum quality due to poor appearance.
https://doi.org/10.1371/journal.pntd.0009643.t001
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also collected NP specimens throughout the follow-up period, and documented detection
throughout the 8-week period, although in fewer numbers, more intermittently, and at higher
Ct counts compared to sputum. Respiratory symptoms were more common among those
Cryptosporidium-positive in respiratory and GI tract compared to positive in GI tract alone,
although again these findings were not statistically significant. In contrast to the Uganda
study, which only collected sputum samples from children with cough, unexplained tachypnea
or hypoxia, we collected respiratory specimens in all participants at enrollment and noted that
Table 2. Longitudinal detection of Cryptosporidium in stool and respiratory tract and associated symptoms.
Characteristics Study period
Enrollment (n = 37) 2 weeksa (n = 27) 4 weeksb (n = 24) 6 weeksc (n = 26) 8 weeksd (n = 25)
Cryptosporidium detection
Detection in NP 4 (11%) 5 (19%) 2 (8%) 1 (4%) 2 (8%)
NP Ct values (SD) 33.5 (1.0) 33.7 (2.0) 35.6 (0.6) 35.7 36.6 (0.7)
Detection in sputum 11 (31%) 10 (37%) 10 (42%) 8 (31%) 5 (20%)
Sputum Ct values (SD) 31.1 (4.4) 29.9(3.6) 33.0 (2.6) 34.3 (2.9) 35.7 (2.6)
Detection in GI tract 37 (100%) 22 (81%) 16 (67%) 11 (42%) 11 (44%)
Stool Ct values (SD) 28.8 (4.3) 26.0 (4.5) 30.3 (2.8) 31.3 (3.5) 29.9 (4.1)
Detection in respiratory tract only 0 0 1 (4%) 3 (8%) 2 (8%)
Detection in GI tract only 27 (73%) 12 (43%) 7 (29%) 5 (19%) 8 (32%)
Detection in respiratory and GI tract 10 (27%) 9 (33%) 9 (26%) 6 (23%) 3 (12%)
Presentation
Referral to health facility for an illness in the past 7 days 36 (100%) 10 (37%) 6 (25%) 5 (19%) 7 (28%)
Diarrhea in the past 7 days 36 (100%) 0 2 (8%) 4 (15%) 3 (12%)
Respiratory symptoms in the past 7 dayse 26 (72%) 9/10 (90%) 4/6 (67%) 2/5(40%) 5/7 (71%)
Cough 24 (69%) 5/10 (50%) 2/6 (33%) 2/5 (40%) 5/7 (71%)
Runny nose 16 (46%) 7/10 (70%) 4/6 (67%) 1/5 (20%) 3/7 (43%)
Difficulty in breathing 1 (3%) 0 0 0 0
Wheezing 4 (11%) 3/10 (30%) 1/6 (17%) 1/5 (20%) 0
Chest indrawings/ retractions 0 0 0 0 0
Crackles 6 (17%) 5/10 (50%) 1/6 (17%) 1/5 (20%) 0/7
Vomiting 16 (46%) 0/10 0/6 1/5 (20%) 0/7
Abdominal pain/ tenderness 11 (31%) 1/10 (10%) 1/6 (17%) 1/5 (20%) 0/7
Poor feeding 14 (40%) 0 0 0 0
Other household members with respiratory symptoms 13 (37%) 1/6 (17%) 3/5 (60%) 0 0
Other household members with GI symptoms 4 (11%) 0 3 (13%) 1 (4%) 2 (8%)
Vital signs
Respiratory rate, breaths/min (SD) 36 (6.1) 34.7 (3.4) 32.8 (3.2) 34.4 (5.7) 32.3 (3.7)
Oxygen saturations, % (SD) 98.6 (1.4) 99.1 (1.2) 98.5 (1.1) 99.4 (0.8) 98.8 (1.4)
Outcome
Mortality 1f (3%) 0 0 0 0
Ct, cycle threshold; GI, gastrointestinal; NP, nasopharynx; SD, standard deviation
aTwo children withdrew at enrollment, one child withdrew after enrollment, five did not enter follow-up due to early stopping of study, and three were lost to follow-up.
bThree children missed week 4 visit.
cOne child missed week 6 visit.
dTwo children did not complete week 8 visit due to early stopping of study.
eIn follow-up study visits, symptoms were recorded only if these led to health facility referral.
fPatient died after discharge before the week 2 visit.
https://doi.org/10.1371/journal.pntd.0009643.t002
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participants with Cryptosporidium positivity in the respiratory tract had respiratory symptoms
in just over half of visits. These data support that almost half the participants with respiratory
Cryptosporidium detection are asymptomatic, and is a lower, rather than upper, respiratory
tract pathogen or colonizer [19–22].
The continued detection of Cryptosporidium in both GI and respiratory tract over 8 weeks
may reflect the young age of this population. A study in Bangladesh noted that children�2
years positive for Cryptosporidium shed it for a mean of 4.1 weeks, which was significantly
Fig 1. Comparison of Cryptosporidium detection in GI and respiratory tracts (mean cycle threshold with 95%
confidence intervals) over 8 weeks in children hospitalized with diarrheal disease.
https://doi.org/10.1371/journal.pntd.0009643.g001
Fig 2. Patient-level dynamics of Cryptosporidium detection in GI and respiratory tracts over 8 weeks in a: A) 10
month-old; B) 14 month-old; C) 14 month-old; D) 7 month-old; E) 11 month-old; F) 11 month-old; G) 10 month-old;
and H) 15 month-old.
https://doi.org/10.1371/journal.pntd.0009643.g002
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longer than those >2 years (mean 1.7 weeks) [23]. However, that was a household transmis-
sion study and did not evaluate children hospitalized with diarrhea. For respiratory pathogens,
prolonged detection of respiratory viruses has been noted in a community surveillance study
in Utah, with significantly longer detection noted in children <5 years (mean 1.9 weeks) com-
pared to other age groups (mean 1.6–1.7 weeks) [24]. To our knowledge, prolonged detection
in the respiratory tract has not before been described for a protozoan parasite; this was not
associated with higher prevalence of respiratory symptoms.
Prevalence of cryptosporidiosis is higher in cases of persistent v. acute diarrhea (15% v.
6.1% in a study in Guinea Bissau [5]). Persistent diarrhea has been described for cryptosporidi-
osis with duration of up to 5 months among severely immunocompromised infants [25]. In
the Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the
Consequences for Child Health and Development Program (MAL-ED) study, cryptosporidio-
sis was the fifth highest attributable pathogen in all pediatric diarrhea in the community set-
ting, and had increased frequency among those with prolonged and severe diarrhea [3].
Among our participants, GI symptoms resolved within 2 weeks of hospitalization for all partic-
ipants, but Cryptosporidium was detected in stool for eight participants throughout the 8-week
period. Shedding duration for cryptosporidiosis among children hospitalized with diarrhea in
sub-Saharan Africa has not been described previously using molecular techniques, although in
Malawian HIV-infected adults we documented consistent shedding for up to 8 weeks [26].
Nutritional status may also account for the prolonged detection of up to 8 weeks that we docu-
mented in our study population. Even though the mean WHZ was within normal, the mean
Table 3. Characteristics and associated symptoms in participants with Cryptosporidium detection in GI tract only v. GI and respiratory tract A) at enrollment; B)
at any point throughout study period.
Characteristic At enrollment (n = 37) At any point throughout study period (n = 27)
GI detection only
(n = 27)
GI and respiratory detection
(n = 10)
P value GI detection only
(n = 16)
GI and respiratory detection
(n = 11)
P value
Age, months (SD) 11.3 (5.3) 13 (4.0) 0.370 12.2 (2.3) 12.0 (6.7) 0.922
Male sex 18 (67%) 6 (60%) 0.7664 9 (56%) 8 (72%) 0.448
Z score (SD)
HAZ -1.4 (2.4) -1.3 (1.1) 0.896 -1.6 (2.5) -1.4 (1.9) 0.837
WAZ -1.1 (1.4) -0.6 (1.2) 0.319 -1.1 (1.2) -0.8 (1.2) 0.474
WHZ -0.2 (1.6) 0.0 (1.7) 0.708 -0.1 (1.7) 0.0 (1.6) 0.945
Number of household
members (SD)
4.2 (1.4) 4.3 (1.5) 0.771 4.4 (1.5) 4.1 (0.9) 0.504
Household children <5
years
1.3 (0.7) 1.1 (0.3) 0.449 1.1 (0.1) 1.2 (0.1) 0.696
Pit latrine 26 (96%) 10 (100%) 0.529 16 (100%) 10 (90%) 0.407
Piped water for drinking 4 (15%) 1 (10%) 0.916 2 (13%) 3 (27%) 0.370
Piped water for utensils 19 (69%) 6 (60%) 0.448 13 (81%) 4 (45%) 0.124
Treated water (%) 14 (50%) 2 (20%) 0.142 6 (37%) 5 (45%) 0.710
Residential animals in the
compound
15 (54%) 7 (70%) 0.467 11 (69%) 7 (63%) 1.000
Respiratory symptoms 17 (65%) 9 (90%) 0.223 11 (68%) 9 (81%) 0.385
Enrollment oxygen sats, %
(SD)
98.5 (1.4) 98.8 (1.2) 0.561 98.5% (1.1) 98.3% (1.7) 0.653
GI symptoms 24 (89%) 8 (80%) 0.603 3 (27%) 10 (62%) 0.120
+ 14.1 (0.7) 14.3 (2.1) 0.819 15.9 (2.9) 17.5 (6.6) 0.445
GI, gastrointestinal; HAZ, Height-for-age z score; SD, standard deviation; WAZ, Weight-for-age z score; WHZ, Weight-for-height z score
https://doi.org/10.1371/journal.pntd.0009643.t003
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HAZ and WAZ of recruited participants both met WHO criteria for stunting and wasting, and
41%, 22%, and 10% had HAZ, WAZ, and WHZ<-2, respectively, indicating mild-moderate
malnutrition in this population. Reduced nutritional status could impact host immunity and
predisposition to colonization/infection [27–29].
Cryptosporidiosis has been associated with excess mortality in children who had the infec-
tion in infancy, and this excess mortality persists into the second year of life [4,5]. In our study
we had one death, which occurred in a 7 month-old breastfeeding, HIV unknown male. This
child had anthropometric parameters consistent with severe acute malnutrition (mid-upper
arm circumference 11 cm, HAZ -1.85, WAZ -3.01, WHZ -2.47, no nutritional edema) at time
of enrollment, and an enrollment Cryptosporidium Ct of 23 in the stool but negative in sputum
and NP. At time of enrollment he was afebrile with normal vitals and had mild dehydration,
diarrhea associated with abdominal tenderness and vomiting, as well as runny nose, cough
and wheeze, but no shortness of breath. Death occurred two weeks after hospitalization after
the child developed a cough and fever and was treated at an outpatient health facility.
This study has several limitations. The sample size was small, and the study population was
drawn from a single hospital, and therefore findings may not be generalizable to other settings.
Secondly, we did not evaluate for respiratory co-pathogens in our enrollment specimens,
thereby limiting our ability ascribe symptoms to a single pathogen, although we did document
co-pathogen detection in 84% during the follow-up period. Thirdly, we did not genotype Cryp-
tosporidium to ascertain whether re-infections occurred. However, these limitations are bal-
anced out by the longitudinal observational design, which allowed us to document for the first
time the dynamics of respiratory Cryptosporidium among children hospitalized with diarrheal
disease.
Conclusion
In summary, in this study we demonstrated that over 20% of young children hospitalized with
diarrheal disease in our setting are positive for Cryptosporidium, and they can shed Cryptospo-
ridium in the stool for up to 2 months. Concurrent respiratory cryptosporidiosis can be
detected in a substantial proportion of young children, and detection continues over a pro-
longed period, with detection more prominent in the lower rather than upper respiratory
tract. However, the small sample size limits our ability to make a definitive conclusion.
Nevertheless, this has implications for the development of therapeutics for cryptosporidio-
sis, which is limited currently to nitazoxanide, and which is poorly efficacious in malnourished
children [30,31]. Since malnourished children are in greatest need for Cryptosporidium thera-
peutics, scientists have been actively trying to find new, more effective drugs to treat crypto-
sporidiosis in this population. Because safety is of paramount concern in this age group, those
developing drugs have debated whether a drug that only resides in the GI tract would be ade-
quate for treating cryptosporidiosis in malnourished children, compared to one with broader
systemic distribution [32]. Our findings suggest that the respiratory tract is a significant reser-
voir for Cryptosporidium infection, and that to cure children, may require a drug that distrib-
utes to the lungs as well as the GI tract. Thus, future research on therapeutic development
should focus on drugs that target not only the GI but also the respiratory tract.
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